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Abstract
Exposure to pentachlorophenol (PCP) near a wood treatment plant was investigated by collecting urine samples from residents 
(n=31), following air sampling. PCP was elevated in air and in urine following odor complaints. Airborne levels (8-hr maximum of 
29 μg/m3) were higher than background ones (<1.3 μg/m3). Women more frequently had detectable urine PCP and had higher 
urine PCP than the US general population; men infrequently had detectable urine PCP and were not statistically different from the 
US general population. Approximately 22% (95%CI: 6.41–47, 64%) of the women had urine PCP levels that were above the 95th 
percentile of US women. Moreover, the 75th percentile concentration of community women averaged 4.7 times higher than the 
75th percentile concentration of US women. In all households where at least one partner had detectable levels, women had higher 
PCP levels than men.
Keywords: Pentachlorophenol, biomonitoring, odor complaints.
Resumen
Se investigó la exposición a pentaclorofenol (PCF) en las proximidades de una planta de tratamiento de madera analizando tanto 
muestras de orina de residentes (n=31) como la concentración en aire. El PCF se encontraba en niveles elevados en aire y en orina 
en zonas donde se habían recibido quejas por olores. Los niveles en aire (máximo octohorario de 29 μg/m3) eran más altos que 
los niveles de fondo (<1,3 μg/m3). Las mujeres presentaron con mayor frecuencia niveles de PCF detectables en orina y niveles 
más altos que la población general de USA; en los hombres los niveles detectables de PCF en orina fueron poco frecuentes y sin 
diferencias estadísticamente significativas con los niveles de la población general. Aproximadamente el 22 % (IC 95%: 6,41-47,64%) 
de las mujeres presentaron niveles de PCF en orina que estaban por encima del percentil 95 de las mujeres americanas. Además, 
el percentil 75 de las concentraciones en las mujeres fue en promedio 4,7 veces más alto que el mismo percentil en las mujeres 
americanas. En todas las viviendas donde al menos una persona tenía niveles detectables, las mujeres tuvieron niveles más altos 
que los hombres.
Palabras clave: Pentaclorofenol, biomonitorización, denuncias por olores.
Resumo
Investigou-se a exposição a pentaclorofenol (PCP) nas proximidades de uma industria de tratamento de madeira analisando amos-
tras de urina de residentes (n = 31) bem como a concentração deste composto no ar. Encontraram-se níveis elevados de PCP no ar 
e na urina em áreas onde foram registadas queixas de maus cheiros. Os níveis no ar (máximo de 29 μg/m3 para oito horas) encon-
travam-se superiores aos níveis do tipo de influência fundo (<1,3 μg/m3). As mulheres apresentaram com maior frequência níveis 
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INTRODUCTION
Odors originating from pentachlorophenol (PCP) 
wood treatment are commonly reported by communi-
ties. Odors associated with the PCP process come from 
a mixture of solvents, wood residues, and PCP. Occupa-
tional exposure to PCP can damage the immune system 
and cause reproductive and developmental anomalies; 
yet, little is known about community exposures1. In July 
2003, a private citizen petitioned the Agency for Toxic 
Substances and Disease Registry (ATSDR) for a public 
health evaluation of emissions from a local wood treat-
ment plant in East Point, Georgia (GA) USA. The plant 
treated wood with creosote and PCP. The petitioner be-
lieved that these chemicals had been released into am-
bient air. From October 2003 to March 2004, the ATSDR 
collected air samples and identified many process-re-
lated chemicals, including PCP2. PCP was detected at a 
mean level of 8.3 μg/m3 (and a range from 1.3 to 30 μg/
m3) in 9 of 10 downwind samples. Because of the lack of 
literature available to assess the effects of PCP inhalation 
exposures at those levels, the ATSDR proposed a second 
investigation that included air sampling followed by 
urine sampling2. The objective of this second investiga-
tion was to establish whether or not the urine PCP levels 
of residents within a mile of the wood treatment plant 
were elevated, as defined by the CDC’s National Report 
on Human Exposure to Environmental Chemicals3.  As re-
cent studies have indicated that current PCP use results 
in little or no detectable dioxin exposure, possibly due 
to better PCP formulation, the investigation focused on 
PCP alone4,5.
METHODS 
Sampling for air and urine was conducted within a 
zone where PCP was detected during the previous inves-
tigation. The zone included an area approximately 1 mile 
downwind from the plant in which approximately 2000 
people live. At a community meeting with over 200 at-
tendees, we presented the findings of our first (air) inves-
tigation and proposed a plan for a follow-up investiga-
tion focusing on PCP in urine.  We presented a map with 
the wood treatment plant in the center and a circle pro-
viding a one-mile radius around the plant.  The map was 
divided into four pie-shaped wedges of different colors 
to represent different wind sectors (Figure 1). Volunteers 
were asked to determine which sector they lived in, and 
to provide their contact information on a colored sheet 
corresponding to the relevant sector.  Information was 
only requested from those volunteers who spent more 
than 12 hrs in the sector each day.  Several dozen resi-
dents volunteered, and several indicated that they had 
additional family members who lived with them. One 
sector was represented by only one volunteer; there-
fore, this sector was visited to recruit other potential 
volunteers. Additional letters and e-mails were sent to 
the community, along with our contact information. In 
all, over 80 community people were willing to participate 
in the study. The residents were asked to call the ATSDR 
during an odor event.  Soon after the time of the calls, air 
was sampled downwind of the plant and near the homes 
of residents who telephoned. All neighboring volunteers 
were contacted from the list of volunteers in each sector, 
and these volunteers visited other neighbors close by to 
secure urine samples. All urine samples were collected 
within three days of the air sampling.
A. Air sAmpling
In the first investigation, which took place between 
Octover 2003 and March 2004, the ATSDR collected 10 
PCP-related downwind air samples. In the second inves-
tigation, between Octover 2004 and September 2005, 
the ATSDR collected 14 PCP-related air samples5. Each 
air sampling event was triggered by an odor complaint 
downwind of the plant. The samples were collected on 
the properties of volunteers who were home on that 
day or in the public right-of-way in their sectors. The 
sampling locations are indicated in Figure 1. No on-site 
weather data were collected. PCP in air samples was col-
lected with sorbent tubes, consistent with Occupational 
Safety and Health Administration (OSHA) method num-
ber 39 for the determination of PCP in air. The samples 
were collected by use of personal sampling pumps at a 
rate of 0.2 L/min over an 8-hour period. Samples were 
de PCP detetáveis na urina e tinham níveis mais elevados de PCP na urina do que a população em geral dos USA. Nos homens foi 
pouco frequente a identificação de níveis de PCP detetáveis na urina e sem diferenças significativas relativamente à população 
em geral. Aproximadamente 22% (IC 95%: 6,41-47,64%) das mulheres apresentaram níveis de PCP na urina que estavam acima do 
percentil 95 das mulheres americanas. O percentil 75 das concentrações nas mulheres foi em média 4,7 vezes superior ao mesmo 
percentil nas mulheres americanas.
Em todos os agregados familiares, onde pelo menos uma pessoa possuía níveis detetáveis, verificou-se que as mulheres apresen-
tavam sempre valores mais elevados que os homens.
Palavras-chave: pentaclorofenol, biomonitorização, queixas de maus cheiros.
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shipped to the laboratory according to chain of custody 
and storage procedures, and were then analyzed by high 
performance liquid chromatography/ultraviolet detec-
tion. One trip blank was sent along with each round of 
samples. Although this methodology is less sensitive 
than others, it does offer portability of equipment, sim-
plicity of deployment, and protection from tampering. 
This analytical method offers 96% (±13.5%) recovery for 
up to 19 days, and the coefficient of variance is 0.0106. 
The analytical standard error for the method is less than 
the variability of the pump flow rates. The flow rates for 
each analyzed sample in this investigation varied by less 
than 15% during sampling; however, the range of flow 
rates for all analyzed samples varied by as much as 41% 
(range 0.18–0.27 L/min).
Figure 1. Exposure Investigation. Recruitment Areas
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B. Urine sAmpling
During the second investigation, October 2004 to 
September 2005, the ATSDR collected 34 urine samples 
(from 31 residents and 1 ATSDR investigator). Among 
these 34 urine samples, two were collected from a single 
resident and two were collected from one of the ATSDR 
investigators (once after the ATSDR investigator spent 
time in the area and once after the investigator spent 
time away from the area). Community samples were col-
lected at 20 households marked on Figure 1. Employees 
of the facility and children under 6 years of age were 
excluded from the study. This age limitation afforded a 
comparable age group with the sample in the CDC’s Re-
port on Human Exposure to Environmental Chemicals7.
Residents on the lists were contacted during the air 
sampling to provide urine samples the following day. 
Immediately following air sampling, ATSDR staff visited 
the volunteers and their neighbors. Available residents 
provided urine samples within a few days  following the 
air samples. A spot urine sample from each person was 
obtained because spot samples are 1) easier and more 
convenient for the community members, thereby maxi-
mizing compliance, and 2) consistent with the methodol-
ogy used by the Centers for Disease Control and Preven-
tion (CDC) to evaluate the US population7. After signing a 
consent form, each participant received an acid-washed 
specimen container and was instructed to provide a spot 
urine sample. Participants were instructed to place the 
filled container in a zip-lock bag and refrigerate it until 
ATSDR staff returned to collect it. Written instructions 
were also provided. The urine samples were analyzed by 
the National Center for Environmental Health (NCEH)/
CDC laboratory in Atlanta, GA, following the protocol de-
scribed in Hill and Needham et al. (1990)8.
C. stAtistiCAl AnAlytiCAl methods
Ten PCP-related air samples were collected in the first 
investigation, and 14 air samples and 34 urine samples 
during the second one. All 24 air measurements were 
plotted using a Robust Regression on Order Statis-
tics (ROS) plot. A test was then carried out to verify the 
log-normality assumption using the applied paramet-
ric model (cenreg function), controlling for dates (Lee 
2010)9. Subsequently, air PCP was compared with the 
closest urine PCP results. Two air samples were exclud-
ed from this statistical analysis, because they were not 
from areas close to the volunteers. In addition, two urine 
samples from the ATSDR investigator and one duplicate 
urine sample from one resident were excluded, with 31 
samples remaining for statistical analysis. 
The air analysis presented here involved comparing 
the frequency at which PCP was detected in the air at 
the same time it was detected in the urine samples of the 
male and female volunteers. The comparison was carried 
out by calculating odds ratios for periods when PCP and 
urine were both in agreement and periods when they 
were not. The actual air sample closest to the resident 
was used directly. Some air samples were taken close to 
the residences of several volunteers; other air samples, 
however, were not as close to the residences of some 
volunteers as we would have desired, but they were the 
most suitable available. From these same data, the Rela-
tive Risk, Chi-Square, and Phi Coefficient were calculated. 
Urine results were reported as raw results, and they 
were creatinine-corrected. Creatinine-corrected PCP lev-
els adjust for the effects of urine dilution to track a per-
son’s relative PCP levels. Raw (uncorrected) results were 
used for comparing the group with results from other 
populations, and the corrected values were used to in-
terpret an individual’s relative values. Populations are 
more appropriately compared by use of uncorrected val-
ues, because of the mathematical limits in the correction 
formula and the great diversity of creatinine levels in the 
general population10,11. However, both values are provid-
ed here in case other researchers desire to perform some 
other analysis, because corrected values are considered 
appropriate to account for individual differences in hy-
dration12. 
The relatively low participation rate (n=31) introduces 
an element of uncertainty in any comparison of urine test 
results with those of the general population described by 
the NCEH in 2005. As PCP is infrequently detected in the 
United States, there is no geometric mean for the general 
population by which one can compare results. 
The statistical methods appropriate for a small sample 
size were used for our analysis. The first method involved 
calculating percentile groups for our sample and compa-
ring them to the percentile groups of the general popu-
lation for two sets of years, 1999–2000 and 2001–20023. 
Distribution-free statistics were used to estimate percen-
tiles and the 95th percent confidence intervals. With this 
method, the coverage for each percentile group was also 
calculated, because coverage provides the actual confi-
dence interval rather than the 95th percent confidence 
interval. Those confidence intervals that fell below 95 
percent were then regarded as not reliable.
The second method was to use exact statistics to 
calculate the proportion of the investigated commu-
nity (n=31) that was higher than the upper confidence 
limit of the 95th percentile of the general population in 
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the National Health and Nutrition Examination Survey 
(NHANES 1999–2000 and NHANES 2001–2002), as well 
as exact 95% confidence intervals for that proportion. In 
addition, two-sided p-values were calculated using the 
exact test—testing to find out if the proportion of the 
investigated community above the 95th percentile of the 
general population was different from the 5th percentile 
of the general population. 
RESULTS
PCP was found in the community’s ambient air and in 
the residents’ urine. 
A. Air
PCP was detected in 14 of 24 (58%) of air samples 
collected throughout the community during both inves-
tigations. During the second investigation, PCP was de-
tected in 36% (5 of 14) of the air samples, ranging from 
non-detectable (ND, LOD<1.3 μg/m3) to 29 µg/m3. The 
PCP concentrations measured throughout the commu-
nity are shown in Table 1. 
PCP was detected in fewer air samples after urine 
sampling began. The second investigation (shown in 
bold) had more samples collected further from the plant 
(greater distances). When samples collected at the same 
distances and locations from the plant were compared, 
results from both investigations were similar when PCP 
was detected. For example, the maximum of 29 µg/
m3 found in the second investigation (01/05/2005) was 
measured at the same location (1) where 30 µg/m3 was 
measured in the first investigation (10/27/2003). More-
over, 8.1 µg/m3 and 22 µg/m3 were measured at the same 
locations (2 and 4) where measurements of 7.9 µg/m3 
and 22 µg/m3, respectively, were recorded in the first 
investigation. Such similarity was not the case, however, 
for samples collected after April 2005, because no PCP 
was detected after that date. As a result of PCP not being 
detected after April of 2005, there were only four sam-
pling periods to determine any associations between air 
concentrations and distance. Each of those four periods 
showed a decrease of concentration with distance from 
the plant, but peak concentrations varied widely for each 
sampling period. Higher maximum values were found on 
two days, lower maximum values on two days, and no 
detectable PCP on three days. Applying the parametric 
model, controlling for differences in concentrations by 
date, a significant negative association was found be-
tween concentration and distance (p<0.01). The r2 value 
was 0.91 and 0.86 for two (of four) sampling events where 
PCP was detected. 
Table 1. Pentachlorophenol (PCP) concentrations mea-
sured in air at varying distances from the wood treatment 
plant throughout two investigations

























ND = PCP not detected in sample. Detection level = 1.3  µg/m3
Bold values identify air samples collected during the urine sample 
investigation.
B. Urine
Twelve of the 31 (39%) residents had detectable levels 
of PCP in their urine (LOD=0.5 μg/L); the concentrations 
ranged from ND to 6.66 µg/L. Table 2 shows the urine-PCP 
levels for each participant per liter of urine (μg/L) and per 
gram of creatinine (in μg/g of creatinine), together with 
the air sample collected closest to the participant’s resi-
dence.
No urinary PCP level was considered high in the com-
munity, but the percentage of individuals with detect-
able levels was considered to be high. PCP in residents 
ranged from ND to 6.66 µg/L, whereas PCP in the gen-
eral population (n=5023) ranged from ND to 325.19 µg/L 
Rev. salud ambient. 2012;12(2):82-92
Gregory M. Zarus and Lourdes Rosales-Guevara 87
(CDC, 2005)3. In the community as a whole, 39% of the 
tested residents had PCP in their urine, whereas less than 
20% of the general population had similarly detectable 
levels of PCP in their urine. Moreover, the ATSDR investi-
gator had 60% higher corrected (and 32% higher uncor-
rected) PCP levels following the time spent in the area, as 
compared with the levels after time spent away. A simi-
lar difference in PCP levels was not observed in the one 
resident (in house 9) who also spent time in the area and 
time away, but the air concentration associated with that 
resident was also not detected outside that individual’s 
home. 
Further inspection reveals that PCP was dispropor-
tionately higher in women. Nine of 18 women residents 
had detectable levels, compared to only 3 of 13 men resi-
dents. To emphasize these differences, in Table 2 the urine 
PCP levels for women and men are listed separately. The 
first eight households listed in Table 2 are houses with 
two or more participants. Five of the 10 women (50%) in 
these households had detectable levels, while only 1 of 
the 8 men (12%) had detectable levels. Furthermore, in 
every household with both men and women, the women 
had higher levels. Only two homes had both partners at 
home nearly all day for several days, and only two homes 
had the entire family home half the day. This information 
was not provided in a formal survey, but was obtained 
through follow-up conversations. Therefore, the actual 
number of hours spent at home was not certain in many 
households. Nevertheless, although based on only a few 
households, the urine-PCP concentration difference be-
tween males and females in the same household is strik-
ing, and that observed difference does not appear to be 
associated with the length of time either men or women 
spent in the home.
Air concentrations measured at the closest air sample 
from each residence are also reported here. Air samples 
were collected before the urine samples, so that some 
air samples reported in Table 1 have no associated urine 
samples in Table 2. Therefore, there were fewer samples 
in which PCP was detected in both urine and air. On 13 
occasions PCP was not detected in the urine of residents 
within a household or in the associated air sample (analy-
sis to follow). There were five occasions when the women 
had PCP in their urine associated with PCP detected in 
the closest air sample, but there were no such cases for 
men.
Table 2. Participants’ urine PCP concentrations (with and 












1 ND 1.66 (0.57) 3.43
1 0.74 (0.36) 3.43
2 ND 6.66 (5.46) 3.43
3 ND ND 3.43
4 ND ND ND
5 ND ND ND
6 0.55 (1.54) 0.90 (1.67) ND
7 ND ND ND
7 ND ND







12 1.75 (0.78) ND




17 0.58 (0.61) ND
18 2.44 (1.18) 8.10
19 2.73 (2.08) ND
20 3.70 (1.73) 8.10
ATSDR 1.22 (0.76) NS
ATSDR (d) 1.62 (1.22) ND**
ND = Not Detected (LOD urine = 0.5 μg/L and LOD air = 1.3 μg/m3) 
NS = Not Sampled
(d) = Second sample collected after time spent near the plant 
ATSDR = Samples collected from one investigator
Households with >1 participants are shaded (homes1–8) 
*Many samples were collected in the neighborhood, but only the data 
nearest the volunteers are presented.
**The investigator spent time near the plant and at several locations in 
the neighborhood; the community samples were ND.
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C. Air And Urine AssoCiAtion 
Odds ratios for the data provided in Table 2 were used 
to determine the association between PCP in the air and 
urine. A summary of the statistical assessment is provi-
ded in Table 3. From the summary table, it can be seen 
that no statistically significant association was found bet-
ween the detection of PCP in men’s urine and air. When 
PCP was not detected in air (n=10), 33% of the men had 
detectable levels of PCP in urine.
Table 3.  Association between PCP in air and urine for males and females in the community 
PCP Air Results
Male Urine Results Female Urine Results
Detect ND Detect ND
Detected in Air  0    (0%) 4     (40%) 5     (83.3%) 1     (16.7%)
ND in Air 3   (33.3%) 6   (66.6%) 4    (33.3%) 8     (66.6%)
Relative risk (CI) 0 5.0 (0.72-34.7)
Odds Ratio 0 10.0 (0.85-117)
(CI) = 95% Confidence Interval 
ND = PCP Not Detected
The association in women is apparent, but not sta-
tistically significant. When PCP was detected in air (n=9), 
83.3% of the women had detectable levels of PCP in urine. 
As with the men, 33.3% of women had detectable urine 
PCP levels when PCP was not found in air. The resulting 
relative risk for women was 5, elevated, and the confi-
dence interval contained the null value of 1, indicating 
that the result was not statistically significant. Chi-Square 
value was 4 with a probability of 0.0455 and the Phi Coef-
ficient was 0.4714.
d. Urine CompArison Between CommUnity And generAl popUlA-
tion
Two statistical methods were required to show the 
difference between the exposed community and the 
general population. Table 4 provides concentrations for 
the percentile groups of men and women in the exposed 
community and the general population. 
Table 4. Pentachlorophenol (PCP) in the urine of residents near a wood treatment plant: comparison with the US po-
pulation
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Note: LOD PCP in urine for NHANES 1999–2000 is 0.25 μg/L, and for NHANES 2001–2002 it is 0.50 μg/L(National third report, page 461).  LOD for 
this study is 0.50 μg/L.<LOD=0.35= 0.5/√(2).
*The difference between the urine PCP levels for men and women for all percentile groups of the exposed community were not statistically 
significant using distribution free statistics.
†There were too few samples to permit calculation of 95% confidence intervals for the 90th and 95th percentile by use of distribution free statistics; 
therefore, the range overlaps the 75th lower confidence level.
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As only a small number of the exposed population 
volunteered for urine tests, the distribution free 95th con-
fidence intervals for most of the percentile groups over-
lap.  However, the 75th percentile can be compared. The 
confidence interval of the 75th percentile for women in 
the community overlaps with that of men for the com-
munity, but it is higher than those for men and women in 
NHANES. Therefore, despite the small number of volun-
teers, there is still sufficient statistical power to suggest 
that women in the community had higher PCP levels 
than women in the two NHANES surveys.
Exact statistics were also used, again because of the 
small number of urine samples, to compare portions of 
the community that were higher than the 95th percentile 
of the general population. This comparison was under-
taken by determining the percentage of the community 
that was higher than the upper confidence level of the 
95th percentile of both NHANES reports (from Table 3); 
the upper confidence levels were 2.20 μg/L and 3.09 μg/L 
for men, and 2.00 μg/L and 2.42 μg/L for women.
By definition, it would be expected that only 5% of 
the women (and men) would be above the 95th percen-
tile group. However, the results of the exact statistics 
found that over 22% (95% CI: 6.4–47.6) of the women of 
the investigated population were above the 95th percen-
tile group of the previous two NHANES. The p-value was 
0.021 for two-sided hypothesis testing (less than 0.05).  
The percentage for men in the community was not 
statistically higher; only 7.69% (95% CI: 19–36.0) above 
that for the 95th percentile of either NHANES, with a p-
value of 0.97. Only the percentage for women in the com-
munity was significantly higher than that for women of 
the general population.
The results of both analyses indicate that when com-
pared to the general population, women of the commu-
nity were more likely to have detectable PCP levels and 
more likely to have higher concentrations of PCP in their 
urine. Men of the community were not more likely to 
have detectable levels and not more likely to have sta-
tistically higher levels than the general population. How-
ever, the differences observed between the men and 
women of the community in both these analyses were 
not statistically significant.
DISCUSSION
Background ambient air PCP levels are estimated to 
range from 0.00015 to 0.136 µg/m3 in the United States, 
and from 0.00043 to 0.00368 µg/m3 in Canada13,14. In the 
studied community, the four (of 24) highest air concen-
trations were more than 200 times higher than the high-
est reference background levels. 
To provide further perspective on the air exposures in 
this community, note that indoor PCP ranged from 0.2 to 
0.38 μg/m3 in a PCP-treated log homes study15. Other log 
home studies16 found PCP ranging from 0.5 to 104 μg/
m3. At several production, application, or pressure opera-
tions6,17,18, PCP ranged from 0.3 to 50 μg/m3. At seven PCP 
dipping plants, and at 11 PCP spray plants19, PCP in the air 
ranged from 3 to 69 μg/m3. Therefore, the ambient con-
centrations found during this investigation —although 
not sufficient to allow determination of a statistical aver-
age— are among those levels considered to be high.
The highest urine PCP levels in the community and 
the National Survey were lower than the lowest urine lev-
el (950 µg/L) shown to have renal effects in men12. How-
ever, few studies involving PCP-exposed women include 
urine testing. We did not find any supporting evidence 
from a literature search to indicate higher urine PCP 
concentration in women than in men. Such a finding for 
PCP was not observed in the US general population3, nor 
was it reported in the previous US general population 
studies20,21,22,23 or in any of the log home studies24,25,15,16. 
Only one human exposure study reported a PCP concen-
tration difference between males and females. However, 
that particular study25 reported the difference in serum 
levels and found that male concentrations were higher, 
and also reported that serum PCP in the general popu-
lation was more frequently detected in males and avera-
ged higher in males. These higher levels were expected 
due to widespread worker exposures, and not due to me-
tabolic (or toxicokinetic) differences between the sexes6.
While PCP metabolism and toxicokinetics have been 
studied only in men, they have been studied in animals 
of both sexes26,27,28. In animals, kinetic differences bet-
ween the sexes have shown that:
•	 Absorption was faster in females of both monkeys 
and rats. 
•	 Female monkeys absorbed PCP twice as fast as the 
males, and female rats absorbed PCP 78% faster than 
the males. 
•	 Of all animals tested, plasma PCP concentrations 
were consistently higher in females. 
•	 The absorption half-life in men —1.3 hours— is simi-
lar to that in male rats, but slower than the half-life in 
male monkeys.
•	 Animal kinetics can be compared only with men, as 
no women have been studied.
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Elimination is relatively slow and first order in men27. 
The half-life of PCP in the body appears to be 3 days from 
an oral dose and perhaps as long as 20 days following 
inhalation exposure26,27,28,29,30. Both enterohepatic circu-
lation and plasma-protein binding influence elimination 
kinetics. Other absorption and elimination data that 
apply to our episodically exposed community provide 
evidence of faster absorption and elimination following 
single doses12,28,30,31.
IMPLICATIONS
The toxicokinetic differences between women and 
men have implications for women’s health. Several stu-
dies suggest that women are uniquely affected by PCP 
exposures; animal studies and worker investigations su-
ggest similar unique health effects. When minks were ex-
posed to technical grade PCP, only the females exhibited 
a decrease in relative thyroid weight32. In a developmen-
tal study of technical grade PCP in rats, most developing 
females did not survive, while the males did32. Although 
this result was not repeated in other studies, significant 
increases in the time of vaginal patency and preputial 
separation were observed34,35,36,37. A recent study on water 
fleas found that females have a lower tolerance to acute 
PCP exposures; a 60% lower effective concentration (EC50) 
was reported for females than for males38. In a study of 
upholstery workers, women with a mean blood PCP level 
of 73 μg/L had an association with infertility, and those 
with a mean of 42 μg/L had an association with menstru-
al dysfunction39. Unfortunately, blood PCP is not as easily 
compared in these worker studies, because PCP levels 
in blood tend to be higher than in urine in worker stud-
ies; in fact, 2 to 10 times higher in blood than in urine4. 
Further study of these women found gynecological and 
endocrine disorders associated with elevated (median 
level of 35 μg/L) PCP in blood40,41. This contrasts with the 
findings in male workers, where no health effects were 
observed in several male workers who had blood serum 
levels as high as 1300 μg/L24,42. The lowest observed level 
associated with effects in men was 2600 μg/L (in blood), 
but these were renal effects12. Recall that the lowest urine 
effect level was 950 in that study.
Our finding of higher levels of urine PCP in women 
(only) has not been reported in other human study po-
pulations, but such higher levels in females have been 
reported in animal studies. As most exposures have been 
due to highly segregated occupations (e.g., women ex-
posed from textiles and men exposed from wood-wor-
king), direct comparison of men to women has not been 
available. However, the log home studies may offer addi-
tional information. In these studies, although sex and age 
urine PCP concentration data were collected, only statis-
tical results for age were reported, showing a significant 
increase in concentrations in children15,24,25. Within the 
raw data of those studies, meaningful information about 
differences in concentrations by sex might be found. In 
the absence of such data, however, we propose that the 
PCP metabolic differences between the sexes observed 
in animals also apply to humans, and we further propose 
that additional studies addressing the metabolic diffe-
rences between men and women are needed. 
LIMITATIONS
This was an investigation rather than a study; so we 
did not have a formal survey or a control population. The 
facility did not advise us when it was treating wood with 
PCP, so that the air sampling was conducted on the basis 
of odor alone. We requested the operations log, but we 
have not yet received a copy. Wind data were not collec-
ted close to the site.
Our results were based on a small sample size. People 
in homes closest to the air sampling devices only partici-
pated a few times. Many people were provided sampling 
jars and did not return them. Our detection levels were 
too high to allow characterization of PCP in residential 
air. Both factors impacted on the odds ratio calculations. 
Moreover, people tend to spend more time indoors than 
outdoors in the locations where the air was sampled. 
CONCLUSIONS
1.  PCP was elevated at times in the air of a communi-
ty located near a wood treatment plant. The levels 
varied widely, but decreased with distance from the 
plant. 
2. PCP detected in the urine of women had a very weak 
(not significant) association with PCP detected in the 
air. No association was found with men.
3. Women in the community had more PCP in urine than 
men in the community and women in the general US 
population; the PCP concentrations in men in the 
community were not significantly elevated. However, 
differences between men and women of the commu-
nity were not statistically significant, due to the small 
number of participants.
4. There are differences in the toxicokinetics of males 
and females that warrant further study of community 
exposures that affect both men and women. 
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